Nesfatin-1: Difference between revisions
CSV import Tag: Reverted |
No edit summary Tag: Manual revert |
||
| Line 27: | Line 27: | ||
[[Category:Endocrinology]] | [[Category:Endocrinology]] | ||
[[Category:Metabolism]] | [[Category:Metabolism]] | ||
Revision as of 01:34, 24 February 2025
Peptide involved in appetite regulation and energy homeostasis
Nesfatin-1 is a peptide that plays a significant role in the regulation of appetite and energy homeostasis. It is derived from the precursor protein nucleobindin-2 (NUCB2) and is expressed in various tissues, including the hypothalamus, pancreas, and adipose tissue.
Structure
Nesfatin-1 is a peptide consisting of 82 amino acids. It is derived from the N-terminal region of the precursor protein NUCB2. The sequence of nesfatin-1 is highly conserved across different species, indicating its important physiological role.
Function
Nesfatin-1 is involved in the regulation of food intake and body weight. It acts as an anorexigenic peptide, meaning it suppresses appetite. Nesfatin-1 exerts its effects by acting on the central nervous system, particularly the hypothalamus, which is a critical region for the regulation of hunger and satiety.
Mechanism of Action
Nesfatin-1 influences energy homeostasis by modulating the release of various hormones. It has been shown to stimulate the release of insulin in a glucose-dependent manner, thereby playing a role in glucose metabolism. The peptide interacts with specific receptors in the brain to exert its anorexigenic effects.
Role in Insulin Signaling
Nesfatin-1 is involved in the regulation of insulin signaling pathways. It enhances insulin sensitivity and promotes glucose uptake in peripheral tissues. This action is crucial for maintaining normal blood glucose levels and preventing metabolic disorders such as diabetes.
Clinical Significance
Due to its role in appetite regulation and energy balance, nesfatin-1 is being studied as a potential therapeutic target for obesity and related metabolic disorders. Understanding the mechanisms by which nesfatin-1 influences energy homeostasis could lead to new treatments for these conditions.